The latest update is out from Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ). Lumos Diagnostics has entered into a distribution partnership with ...
Potentially any day now, the US Food and Drug Administration (FDA) will rule on a request which – if granted – will boost ...
Real-World Impact: Organizations automating identity workflows report massive efficiency gains. A leading fintech company ...
Lumos Labs has obtained a clearance from the FDA for its popular Lumosity brain training platform, greenlighting a version of ...
GlobalData on MSN
FDA greenlights Lumos Labs’ digital ADHD therapeutic
Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...
You'll need to make your way through a moth puzzle-filled dungeon in Hogwarts Legacy in order to get the Helm of Urtkot. Here ...
Lumos Diagnostics is closer than ever to a decision that could redefine its future: an FDA ruling that would open the entire US point-of-care market to Febridx. The submission pertains to a CLIA ...
The collaboration will provide Lumos Diagnostics (ASX:LDX) with greater visibility into how the test is reimbursed under the US Proprietary Laboratory Analyses (PLA) Code #0442U, helping ensure ...
Lumos teams up with AcuityMD to strengthen US commercialisation of its rapid FebriDx test to distinguish between bacterial and non-bacterial acute respiratory infections. The collaboration will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results